Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-01

Clinical Trial Update: Pain Reduction With Intranasal Medications for Extremity Injuries [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intranasal medications for pain reduction in extremity injuries has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Pain, Traumatic Limb Injury | Phase 3 | Status: COMPLETED | Results posted: 2020-09-01